Procter & Gamble (PG) — Q1 2027 Earnings Preview
Key Points
- Guidance for FY27: Organic sales growth of 1% to 3%; core EPS growth of 0% to 3% ($6.89–$7.11); $1B after-tax cost headwind from raw materials, energy, transportation, and supply chain premiums.
- Consensus Estimates for Q1 2027: Revenue $22,749M; gross margin 50.1%; EBITDA $6,479M; net income $4,571M; GAAP EPS $1.86.
- Recent Trends: Q4 2026 organic sales in line with prior year; volume flat; pricing/mix neutral; global share stabilized after sequential improvement in H2 FY26.
- Comparables: Q1 2026 revenue was $22,169M (+6% YoY vs. Q4 2025); Q1 2027 faces a tougher YoY comp due to higher base and ongoing cost headwinds.
- Strategic Focus: Management is prioritizing user growth, innovation-driven value, targeted price interventions, and scaling digital/AI capabilities.
- Watch List for Q1 2027: Margin pressure from input costs, effectiveness of recent pricing and promotional interventions, progress on share gains in key categories (especially U.S. Baby Care, Family Care, Fabric Care), and evidence of category growth reacceleration.
Most Important Factors to Watch This Quarter
| Factor | Why It Matters | What to Watch |
|---|---|---|
| Organic Sales Growth | Guidance is 1–3% for FY27; Q1 sets the tone for the year | Track reported organic sales vs. 2% consensus midpoint; look for signs of share gains |
| Core EPS | Guidance is $6.89–$7.11 for FY27; Q1 faces >5% YoY EPS headwind | Monitor EPS delivery vs. consensus $1.86; margin compression risk |
| Gross Margin | Cost headwinds ($1B after-tax) expected to hit H1 hardest | Any sequential or YoY decline; management focus on productivity offsets |
| Volume vs. Price/Mix | Recent growth has been price-driven; shift to volume/user growth is a key goal | Evidence of volume recovery, especially in U.S. and Europe |
| Category/Region Performance | U.S. and Focus Europe have been volatile; China and Enterprise Markets are improving | Progress in U.S. Baby Care, Family Care, Fabric Care, and China share gains |
| Promotional Activity | Return to pre-COVID promo levels; risk of margin dilution | Depth/frequency of promotions, impact on share and margins |
| Inventory Dynamics | Q4 2026 saw a 3-point gap between sell-in and sell-out | Alignment of shipments and consumption; any further inventory corrections |
| Execution of Interventions | Management has implemented targeted pricing, innovation, and media spend changes | Early results from these interventions, especially in lagging categories |
Quarterly Financials — Actuals and Consensus
Quarterly Results and Consensus (Q1 2027 vs. Prior Year)
| Quarter | Revenue ($M) | Gross Margin (%) | EBITDA ($M) | Net Income ($M) | GAAP EPS | Cash Flow/Share ($) |
|---|---|---|---|---|---|---|
| Q1 2027 (consensus) | 22,749 | 50.1 | 6,479 | 4,571 | 1.86 | 1.77 |
| Q1 2026 (actual) | 22,169 | 51.3 | 6,502 | 4,632 | 1.84 | 1.84 |
| Q4 2026 (actual) | 21,377 | 48.3 | 5,030 | 3,394 | 1.40 | 1.59 |
Note: Q1 2027 consensus figures are estimates, not actuals.
Annual Financials — Actuals and Consensus
| Fiscal Year | Revenue ($M) | Gross Margin (%) | EBITDA ($M) | Net Income ($M) | GAAP EPS | Cash Flow/Share ($) |
|---|---|---|---|---|---|---|
| FY2027 (consensus) | 88,806 | 50.3 | 24,256 | 16,782 | 6.81 | 8.16 |
| FY2026 (actual) | 87,099 | 50.5 | 23,767 | 16,674 | 6.79 | 7.92 |
| FY2025 (actual) | 84,210 | 51.3 | 23,383 | 16,610 | 6.54 | 7.63 |
Guidance Summary — FY27
| Metric | Guidance | Context Notes |
|---|---|---|
| Organic Sales Growth | 1% to 3% | Includes 30–50 bps headwind from restructuring; midpoint assumes 2% category growth and share gains |
| Core EPS | $6.89–$7.11 (0% to +3%) | $1B after-tax cost headwind; Q1 EPS expected down 5%+ YoY; cost pressure skewed to H1 |
| Free Cash Flow Productivity | 85% to 90% | Capital spending 4.5%–5.5% of sales |
| Dividends | >$10B | Consistent with prior years |
| Share Repurchase | ~$5B | Consistent with prior years |
| Total Cash Return | ~$15B | Dividends + buybacks |
| Core Effective Tax Rate | ~20% | In line with prior year |
| FX Headwind | ~$50M after-tax | Modest impact |
| Net Interest Expense | +$150M after-tax | Higher rates |
| Nonoperating Income | -$150M after-tax | Lower YoY |
How Did They Report Last Year? (Q1 2026)
- Revenue: $22,169M (+6% YoY vs. Q4 2025)
- Gross Margin: 51.3%
- EBITDA: $6,502M
- Net Income: $4,632M
- GAAP EPS: $1.84
- Organic Sales Growth: +2%
- Volume: Flat YoY
- Pricing/Mix: +1% each
- Key Commentary: Strong execution in a challenging environment; broad-based growth across most categories and regions; continued investment in innovation and productivity; restructuring program underway.
Are They Coming Off a Tough Comparable?
- Yes. Q1 2026 was a strong quarter with 6% YoY revenue growth and robust margins. The company benefited from broad-based category and regional growth, as well as successful innovation launches.
- FY26 overall: Organic sales grew 1%, with modest volume growth and stable market share in H2. However, cost pressures and softening category growth, especially in the U.S. and Europe, weighed on results.
- Q1 2027 faces: A higher base, ongoing cost headwinds ($1B after-tax), and a more muted category growth environment (guidance assumes 1–3% category growth).
Management Commentary and Strategic Focus
- Execution Overhaul: Management is not changing the core integrated growth strategy but is overhauling execution—faster diagnosis and intervention when user growth stalls, leveraging data/AI, and automating internal processes.
- Innovation and Value: Emphasis on innovation-driven value (e.g., Tide liquid upgrade, Tide evo), targeted price interventions, and improved media efficiency.
- Productivity: Record cost of goods productivity in FY26; further productivity gains expected in FY27 to offset cost headwinds and fund brand investments.
- Category/Region Focus: U.S. and Focus Europe remain priorities for share and category growth; China and Enterprise Markets are showing sustained improvement.
- Promotional Environment: Promotions returning to pre-COVID levels; management intends to use promotion for trial, not as a primary growth lever.
- Digital/AI Capabilities: Scaling Supply Chain 3.0, media transformation, and R&D acceleration via AI/molecular discovery suite.
Summary and Conclusions
- Q1 2027 Preview: Expect modest organic sales growth (1–3%), with margin pressure from input costs and a tough YoY comp. EPS likely down YoY in Q1, per guidance.
- Key Watch Items: Margin resilience, volume recovery, share gains in lagging categories (especially U.S.), and evidence that recent interventions are driving user growth and category expansion.
- Management Tone: Confident in the strategy and interventions, but cautious given macro volatility, cost inflation, and slow category growth in developed markets.
- Catalysts: Acceleration in U.S. and Europe category growth, successful scaling of innovation (Tide evo, Family Care upgrades), and further productivity gains.
Upcoming Catalysts
- Q1 2027 Earnings Release: Will set the tone for FY27, especially on margin and share trends.
- Investor Day (Nov 19, 2026): Deeper dive into capability transformation, innovation pipeline, and long-term growth algorithm.
- Category/Region Interventions: Progress in U.S. Baby Care, Family Care, and Fabric Care; continued share gains in China and Enterprise Markets.
- Cost Environment: Evolution of oil, transportation, and input costs; potential for further pricing actions if cost pressures persist.
In summary: Procter & Gamble enters Q1 2027 with stabilized share, a challenging cost environment, and a focus on executional discipline. The next earnings report will be scrutinized for evidence that interventions are translating into sustainable growth and margin resilience, especially given a tougher comparable and ongoing macro headwinds.
